TV 7314 (Clopidogrel bisulfate 75 mg (base))
Pill imprint TV 7314 has been identified as Clopidogrel bisulfate 75 mg (base).
Clopidogrel is used in the treatment of ischemic stroke; peripheral arterial disease; transient ischemic attack; heart attack; ischemic stroke, prophylaxis (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not subject to the Controlled Substances Act.
See also related documents.
Images for TV 7314 (Clopidogrel bisulfate 75 mg (base))
- 75 mg (base)
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals, USA Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
hydrogenated cottonseed oil
hypromellose 2910 (15 mPa.s)
FD&C Blue No. 2
ferric oxide red
ferric oxide yellow
polyethylene glycol 4000
sodium lauryl sulfate
Clopidogrel bisulfate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...